2026-2034年全球獸用麻醉劑市場規模、佔有率、趨勢和成長分析報告

預計獸用麻醉劑市場將從 2025 年的 5.5352 億美元成長到 2034 年的 10.1933 億美元，2026 年至 2034 年的複合年成長率為 7.02%。

由於寵物數量不斷增加以及對先進獸醫護理需求的成長，全球獸用麻醉劑市場正穩步成長。這些藥物對於動物手術和疼痛管理至關重要，並且能夠確保安全有效的治療。獸醫院和診所的擴張，尤其是在都市區，是推動市場成長的主要因素。

關鍵成長要素包括人們對動物健康的日益關注、寵物照護支出不斷增加以及獸醫學的進步。畜牧管理方式的演變以及對動物福利和生產力的日益重視，進一步推動了對麻醉劑的需求。此外，更安全、更有效的製劑的研發也改善了治療效果。

隨著獸醫基礎設施的完善和先進醫療技術的引入，市場預計將持續成長。研發工作主要集中在提高藥物的安全性和有效性。隨著動物健康日益受到重視，獸用麻醉劑市場預計將實現永續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球獸用麻醉劑市場：依藥物類型分類

• 市場分析、洞察與預測
• 吸入麻醉劑
• 注射麻醉劑
• 止痛藥
• 麻醉前用藥
• 逆轉劑

第5章 全球獸用麻醉劑市場：依動物種類分類

• 市場分析、洞察與預測
• 狗
• 貓
• 馬
• 牛
• 其他

第6章：全球獸用麻醉劑市場：依給藥途徑分類

• 市場分析、洞察與預測
• 靜脈注射（IV）
• 肌肉內注射（IM）
• 皮下（SC）
• 吸入
• 口服

第7章 全球獸用麻醉劑市場：依應用分類

• 市場分析、洞察與預測
• 外科手術
• 牙科治療
• 疼痛管理
• 緊急醫療護理
• 診斷程序

第8章：全球獸用麻醉劑市場：依最終用戶分類

• 市場分析、洞察與預測
• 動物診所
• 動物醫院
• 研究機構
• 居家照護環境
• 學術機構

第9章 全球獸用麻醉劑市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Dechra
  • LGC Group
  • AuroMedics
  • Evonik
  • Gedeon Richter
  • Midas Pharma
  • Fresenius Kabi AG
  • AstraZeneca

The Veterinary Anesthesia Drugs Market size is expected to reach USD 1019.33 Million in 2034 from USD 553.52 Million (2025) growing at a CAGR of 7.02% during 2026-2034.

The global veterinary anesthesia drugs market is growing steadily due to increasing pet ownership and rising demand for advanced veterinary care. These drugs are essential for surgical procedures and pain management in animals, ensuring safe and effective treatment. The expansion of veterinary clinics and hospitals, particularly in urban areas, is contributing significantly to market growth.

Key drivers include increasing awareness about animal health, rising expenditure on pet care, and advancements in veterinary medicine. Livestock management practices are also evolving, with a greater focus on animal welfare and productivity, further boosting demand for anesthesia drugs. Additionally, the development of safer and more effective drug formulations is enhancing treatment outcomes.

Looking ahead, the market is expected to witness continued growth with the expansion of veterinary healthcare infrastructure and increasing adoption of advanced medical technologies. Research and development efforts are focused on improving drug safety and efficacy. As the importance of animal health continues to rise, the veterinary anesthesia drugs market is set for sustained expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Drug Type

• Inhalant Anesthetics
• Injectable Anesthetics
• Analgesics
• Pre-anesthetic Medications
• Reversal Agents

By Species

• Canine
• Feline
• Equine
• Bovine
• Others

By Administration Route

• Intravenous (IV)
• Intramuscular (IM)
• Subcutaneous (SC)
• Inhalation
• Oral

By Application

• Surgical Procedures
• Dental Procedures
• Pain Management
• Emergency Care
• Diagnostic Procedures

By End User

• Veterinary Clinics
• Animal Hospitals
• Research Institutions
• Home Care Settings
• Academic Institutions

COMPANIES PROFILED

• Dechra, LGC Group, AuroMedics, Evonik, Gedeon Richter, Midas Pharma, Fresenius Kabi AG, AstraZeneca
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY ANESTHESIA DRUGS MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug Type
• 4.2. Inhalant Anesthetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Injectable Anesthetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Analgesics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Pre-anesthetic Medications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Reversal Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY ANESTHESIA DRUGS MARKET: BY SPECIES 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Species
• 5.2. Canine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Feline Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Equine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Bovine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY ANESTHESIA DRUGS MARKET: BY ADMINISTRATION ROUTE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Administration Route
• 6.2. Intravenous (IV) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Intramuscular (IM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Subcutaneous (SC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Inhalation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY ANESTHESIA DRUGS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Surgical Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Dental Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Emergency Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Diagnostic Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY ANESTHESIA DRUGS MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Veterinary Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Animal Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Academic Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL VETERINARY ANESTHESIA DRUGS MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Drug Type
  • 9.2.2 By Species
  • 9.2.3 By Administration Route
  • 9.2.4 By Application
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Drug Type
  • 9.3.2 By Species
  • 9.3.3 By Administration Route
  • 9.3.4 By Application
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Drug Type
  • 9.4.2 By Species
  • 9.4.3 By Administration Route
  • 9.4.4 By Application
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Drug Type
  • 9.5.2 By Species
  • 9.5.3 By Administration Route
  • 9.5.4 By Application
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Drug Type
  • 9.6.2 By Species
  • 9.6.3 By Administration Route
  • 9.6.4 By Application
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL VETERINARY ANESTHESIA DRUGS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Dechra
  • 11.2.2 LGC Group
  • 11.2.3 AuroMedics
  • 11.2.4 Evonik
  • 11.2.5 Gedeon Richter
  • 11.2.6 Midas Pharma
  • 11.2.7 Fresenius Kabi AG
  • 11.2.8 AstraZeneca